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Abstract.  Mutational studies were previously carried 
out at the co site in intact cells (Micanovic, R., L. 
Gerber, J. Berger, K. Kodukula, and S. Udenfriend. 
1990.  Proc.  Natl. Acad.  Sci.  USA.  87:157-161; Mican- 
ovic R., K. Kodukula, L. Gerber, and S. Udenfriend. 
1990. Proc.  Natl.  Acad.  Sci.  USA: 87:7939-7943)  and 
at the co +  1 and co +  2  sites in a cell-free system 
(Gerber, L., K. Kodukula, and S. Udenfriend. 1992. 
J.  Biol.  Chem.  267:12168-12173)  of nascent proteins 
destined to be processed to a glycosylphosphatidyl- 
inositol (GPI)-anchored form. We have now mutated 
the co +  1 and co +  2  sites in placental alkaline phos- 
phatase (PLAP) cDNA and transfected the wild-type 
and mutant cDNAs into COS 7 cells. Only glycine at 
the co +  2  site yielded enzymatically active GPI mem- 
brane-anchored PLAP in amounts comparable to the 
wild type (alanine). Serine was less active and threo- 
nine and valine yielded very low but significant activ- 
ity. By contrast the co +  1 site was promiscuous, with 
only prollne being inactive. These and the previous 
studies indicate that the co and ~0  +  2 sites of a na- 
scent protein are key determinants for recognition by 
COOH-terminal signal transamidase. Comparisons 
have been made to specific requirements for substitu- 
tion at the -1,  -3 sites of amino terminal signal pep- 
tides for recognition by NH2-terminal signal peptidase 
and the mechanisms of NH2 and COOH-terminal sig- 
naling are compared. 
p 
ROTEINS that are anchored to the plasma membrane  by 
a  glycosyl-phosphatidylinositol  (GPI)~ moiety  are 
derived from a nascent precursor that contains two 
signal peptides;  one at the NH2 terminus and the other at 
the COOH terminus. The NH2-terminal signal peptide,  af- 
ter directing the nascent protein (prepro  protein) into the 
ER,  is  cleaved by NH2-signal peptidese  to yield the pro 
protein. Secreted proteins that contain no other signal pep- 
tides, are processed by this well-studied mechanism (4). In 
the case of GPI-anchored proteins, the COOH-terminal sig- 
nal peptide apparently directs the pro protein to a putative 
transamidase (8,  10,  15, 30). The latter, which is probably 
present in the membrane of the ER, catalyzes attachment of 
the GPI moiety to an internal residue of the pro protein near 
the COOH terminus (co residue) with concomitant cleavage 
of  the signal peptide. We proposed previously that the amino 
acid in the nascent protein which is present at the putative 
cleavage site of the COOH-terminal signal peptide, to which 
the GPI anchor is attached and becomes the new COOH 
terminus, be designated  as the "co" site  (11). This simpli- 
fies comparisons between the NH~-terminal and COOH- 
terminal  signal  peptldes  and  also  among different GPI- 
anchored proteins which vary in size. Examination of the 20 
1.  Abbreviations  used in  this paper:  GPI,  glycosylphosphatidylinositol; 
PLAP, placental  alkaline phosphatase. 
or so fully characterized  nascent forms of  ON-anchored  pro- 
reins reveals that, with few exceptions, the co residue and the 
two residues adjacent and COOH-terminal to it, i.e., co +  1 
and  co + 2,  are  small  amino acids  (small  amino acid  domain) 
(10, 11).  Mutational studies  carried  out at the co site  of  the 
nascent forms of  placental  alkaline  phosphatase (PLAP) in 
intact  cells  (18,  19)  and  of  the  engineered  protein  miniPLAP 
in  a  cell-free  system (14)  indicated  that  only  glycine,  alanine, 
serine,  cysteine,  aspartic  acid,  and asparagine are allowed. 
These same six  amino acids  are  the  only ones  that  have  been 
reported  to  be  present  at  the  co  sites  of  the  GPI-anchored  pro- 
reins that have been characterized  thus far (8, I0, 11). 
MiniPLAP [23.9  kD] is an engineered protein  designed at 
the eDNA  level  from human PLAP  [57.5  kD]. The en- 
gineered protein retains the NH2 and COOH termini and 
all the antibody recognition sites of PLAP but is devoid of 
the active site, all the putative glycosylation sites and most 
of the cysteines.  MiniPLAP was designed specifically for 
cell-free studies. 
Recently we reported mutational studies at the co +  1 and 
co + 2 sites of  the engineered  protein, preprominlPLAP (11). 
Those studies, that were carried out in a cell-free system, in- 
dicate that there are even greater limitations at the co + 2 site 
than at  the co  site.  COOH-terminal processing  occurred 
equally well with alanine or glycine at the co + 2 sites. How- 
ever, of the other amino acids tested only the serine mutant 
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promiscuous,  only the proline mutant being inactive.  We 
have now carried out comparable mutational studies at the 
~0 +  I and ~o +  2 sites of wild-type PLAP in transfected COS 
cells to determine whether the same site specificities apply 
to processing  of a  natural GPI-anchored protein in intact 
cells. 
Materials and Methods 
Mutagenesis and Recombinant Plasmids 
The to +  I and w +  2 mutants of pBCI2BI/PLAP 513 AKpn were made 
by treating the ~0 +  1 and ~0 +  2 mutants of pGEM4Z/miniPLAP 208 (11) 
with Asp718 and  Ec/XI (Boehringer Mannheim  Biochemicals,  Indianapolis, 
IN) to produce a 632-bp fragment containing the mutation sites. The origi- 
nal pBC12BI/PLAP 513 AKpn was also treated with Asp718 and Ec/XI to 
produce two fragments, 4,770 and 632 bp. The 632 bp fragment from each 
mutant and the 4,770 bp fragment from pBCI2BI/PLAP 513 AKpn were 
gel purified,  eluted from the gel using Spin-X tubes (Costar,  Cambridge, 
MA), ethanol precipitated, and redissolved  in water. The solutions were 
quantified,  mixed 3:1 (tool/tool) small fragment to large fragment, and 
ligated ushn_g  T4 ligase (New England Biolabs, Beverly, IDA). The resultant 
+  1 and ~  +  2 mutants of pBCI2BI/PLAP 513 AKpn were then used 
to transform competent DH5c~ cells (New England Biolabs).  The plasmids 
were screened  with"appropriate  restriction  enzymes, and DNA  sequences 
were verified by sequencing,  by the dideoxy method, using the TAQuence 
Version  2.0  DNA Sequencing  Kit (Unit~ States Biochemical, Cleveland, OH). 
In each of the mutants studied, the substitutions were made specifically 
at ~o +  1 or c0 + 2 sites, and in each case the wild-type residues were main- 
tained at adjacent positions.  For example, when mutating alanine at co +  1, 
the wild-type amino acids at ~0 and ~  + 2 (aspartic acid and aianine, respec- 
tively) were preserved, thus the ~0 +  I mutants w~d have a sequence Asp- 
X-AIa and the ~0 +  2 mutants ha~e an Asp-Ala-X motif in the small amino 
acid domain. Similarly, the site mutations at the ~0 position had an X-Ala- 
Ala motif as reported earlier (18, 19). 
Cell Culture and DNA Transfections 
COS 7 cells were maintained in culture as described (12) and transfections 
were  carried out in 35-ram weft  culture plates,  by the DEAE-Dextran 
method (9). Approximately 300-350 ng of DNA per well was used for each 
transfection.  Mock transfections  were carried out substituting PBS for DNA 
in the trandection cocktail. Transfections were typically carried out in qua- 
druplicate wells for each mutant. 
Metabolic Labeling 
Metabolic labeling of ceils with [35S]methionine was carried out 48-60 h 
after transfr  For steady state labeling, cells wcrr  starved of methio- 
nine by preincuhating for 1 h at 37~  in 2.0 ml of methionine-free DME 
supplemented  with 5% dialyzed  FBS (Oihco Laboratories, Grand Island, 
NY).  Fresh mndium containing [3SS]methionine (,~200 ~tCi per 35-ram 
well; 1.0 Ci = 37.0 GBq; ~ham  Corp., Arlington  Heights, IL) was then 
added and incubation  was continued for 12-16 h. 
]~eatment of Cells with Phosphatidylinositol Specific 
Phospholipase C (PI-PLC) 
PLAP,  from either radiolabeled or unlabeled transfectants, was released 
with phosphatidylinositol  specific phospholipase C (PI-PLC) purified from 
Bacillus thuringiensis (28).  Each culture well was washed twice with 2.0 
ml of PBS and twice with release buffer (25 mM "IYis/HCI, pH 7.5, 10 mM 
glucose,  250 mM sucrose).  Subsequently  duplicate wells for each mutant 
were treated with 1.0 ml of  release buffer containing  protease inhibitors (an- 
tipain, aprotinin, bestatin, chymostatin, leupeptin, and pepstatin, each at 
0.2 pg/ml) and PI-PLC (125-150  U/well).  One unit of PI-PLC activity is 
defined as that amount of enzyme that will hydrolyze  8  x  10  -~ pmol of 
phosphatidylinositol in 1 rain at 37~  PI-PLC was omitted from the above 
mixture while treating control wells  for each mutant. Samples  were in- 
cubated at 37~  for 2 h, supernatants were transferred to eppendorf robes 
(Brinkrnan Instruments, Inc., Westbury, NY) and cell debris was removed 
by centrifugetion (14,000 g for 10 rain). 15-20-pl aiiquots were taken from 
the supernatant to measure PLAP activity. The remaining cells on the cul- 
ture plate were scraped into 2.0 ml of PBS,  washed once with PBS,  and 
resuspended in 100/d of homngenization buffer (50 mM Tris/HC1, pH 7.5, 
1.0 pM magnesium chloride, and 20 mM zinc sulfate). Homogenization was 
carried out using a hand held micro-homogenizer and aliquots of the ho- 
mngenate (2.0-4.0 p.l) were taken for measuring PLAP activity. 
Alkaline Phosphatase and Protein Assay 
PI-PLC-treated supernatants or total cell homogenates were assayed  for 
alkaline phosphatase activity using p-nitrophenyl phosphate as substrate 
(16). 1 mU of  the enzyme produces an absorbance change of 0.04 per minute 
at 405 nm at room temperature (23~  Traces of  endogenons alkaline phns- 
phatases in COS cells were inhibited  by adding 10 mM (final concentration) 
L-homoarginine to the reaction mixture.  The assay is therefore specific for 
PLAP. The cell homogenates were treated with 0.1% SDS and total protein 
concentrations were estimated by the Bradford  method (14). 
lmmunoprecipitation and SDS-PAGE 
An aliquot of each PI-PLC treated supernatant (900 pl) was added to 100 
#1 of 10% SDS-20% ~-mercaptoethanol (vol/vol), and the mixture was first 
vortexed and then boiled for 5 rain. A 200-pl aliquot of the boiled mixture 
was diluted to 1.0 ml with radio immunoprecipitation buffer (3) and PLAP 
related proteins were precipitated by adding anti-PLAP polyclonai antibody 
(Accurate Chemical Corp.,  Westbury,  NY) at 1:500 and incubating for 
12-16 h at 4~ 
Whole cell lysates were prepared for immunoprecipitation in the follow- 
ing manner.  Metabolically labeled cells were lysed directly on each plate 
with 400 pl of 2 % SDS-5 % ~-mercaptoethanol (vol/vol), transferred to ep- 
pendorf tubes and boiled for 5 rain. Boiled lysate (200 pl) was diluted to 
1.0 mi with RIPA buffer (1% Triton X-100, 0.5% dcoxyvholate, 0.2% SDS, 
100 mM NaCI,  1 mM EDTA, 50 mM Tris-HC1, pH 7.5) and treated with 
antibody,  as  described  above.  The  immunoprecipitated samples  were 
treated with protein A~pharosr CL-4B (Sigma Chemical Co., St, Louis, 
MO) and incubated for 1 h on a rotator. Samples were then extracted into 
2  x  SDS-PAGE sample buffer and electrophoresis was carried out on 7. 5 % 
polyacrylamide  gels. After electrophoresis gels were fixed, treated with am- 
plify (Amersham Corp.), dried, and exposed to X-OMAT-AR film (East- 
man Kodak Co., Rochester,  NY). 
Immunofluorescent Labeling of Cells 
Immunoflnorescent labeling of transfect~ cells was carried out in 35-ram 
culture wells as described (9). At 72 h post-transfection,  cells were fixed 
with 95% ethanol-5% acetic acid at -20~  for I0 mill and then washed 
three times with cold PBS. To block non-specific  binding, cells were in- 
cubated with normal goat serum for 16 h at 4~  and were then washed with 
PBS and incubated with anti-PLAP antibody (diluted  1:500) in BSA buffer 
(1% BSA, 0.3 % gelatin, 25 mM sodium phosphate, pH 7.5, 150 mM sodium 
chloride). After this, the cells were washed with PBS to remove unbound 
antibody and finally incubated with fluorescein-conjngated  goat anti-rabbit 
IgG (Organon Teknica,  West  Chester,  PA) diluted  1:50 in triton buffer 
(0.3% Triton X-100 in PBS). Finally, the labeled cells were mounted under 
glycerol/PBS  (9:1, vol/vol) containing 5% n-propyl gailate and examined 
under a fluorescence  microscope.  Photomicrography was carried out using 
Ektachrome 800 P film (Eastman Kodak Co.). 
Results 
Expression of  co +  1 and co +  2 Site~irected Mutants 
of PLAP and Processing to GPl-anchored Forms 
The mutants that were investigated are shown in Fig. 1. Each 
was transiently expressed in COS ceils  and monitored by 
psS]methionine labeling  followed by immunoprecipitation 
with the polyclonal antibody to PLAP.  As shown in Fig.  2 
A, all the co +  1 mutants yielded PLAP-related proteins with 
the same molecular masses as wild-type PLAP and the ex- 
tent of expression was comparable, within experimental er- 
ror, for all mutants. Each of the w  +  1 mutant forms (with 
the exception of proline) yielded a broadened band in the 
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CO +1 mutants  CO +2 mutants 
All (wt)  AIB (wt) 
ASp  Met  Asp  Val 
Ser  Arg  Set  Glu 
Cys  Trp  Cys  His 
Thr  Pro  Thr  Pro 
Gly 
Figure 1. The COOH terminus of PLAP indicating  the signal pep- 
tide that is cleaved during GPI addition.  The arrow indicates  the 
site of cleavage and ~ represents  the terminal amino acid residue 
of the mature protein to which the GPI moiety is attached. 
range  of 65  to 70  kD.  Based  on  earlier  studies  (19),  this 
represents a mixture of the proPLAP form (ca. 65 kD) and 
the mature,  GPI-anchored form of PLAP (ca. 68 kD).  The 
resolved, faster running band (ca. 60 kD) represents the na- 
scent protein,  preproPLAP.  Wild-type PLAP, like all GPI- 
anchored proteins,  can be released from the cell surface by 
PI-PLC (10,  15). Accordingly, cells transfected with each of 
the w  +  1 mutant cDNAs and labeled with [35S]methionine 
were treated with PI-PLC. Aliquots of the PI-PLC-treated 
supernatants  were  immunoprecipitated  with  antibody  and 
the labeled  PLAP-related proteins  were resolved on SDS- 
PAGE.  Fig.  2  B  shows protein  released  into the medium. 
PLAP  was  not  released  from  control  cells  that  were  not 
treated with PI-PLC (data not shown).  Except for proline, 
PI-PLC treatment released mature forms of PLAP from all 
o~  +  1 mutants.  The amount released from the tryptophan 
mutant was small but significant. The PI-PLC-released pro- 
teins appear as single broad bands at 68 kD.  Broadening is 
most likely due to glycosylation during processing. 
Expression ofo~ +  2 mutants is shown in Fig. 3 A. As with 
w  +  1 mutants all mutant forms were expressed.  It should 
be noted, however, that,  in contrast to w  +  1 mutants (Fig. 
2 A) not all of  the oJ +  2 bands were broadened. The explana- 
tion for this becomes apparent when one examines Fig. 3 B 
which shows the release of the GPI-anchored forms of PLAP 
from the cell surface by PI-PLC. Only four of the mutants 
yielded PI-PLC releasable  PLAP that migrated at 68  kD; 
Figure 2. Expression of w +  1 
mutants  of  PLAP  in  COS 
cells.  Transfected  COS  ceils 
were  metabolically  labeled 
with [35S]methionine and pro- 
teins from whole cell lysates 
or PI-PLC treated supernatants 
were immunoprecipitated  with 
anti-PLAP  antiserum  and 
subjected  to SDS-PAGE.  (A) 
Total  PLAP from whole cell 
lysates. Wild-type PLAP and the various mutants yield broad bands 
indicating  that they are extensively  glycosylated and represent  a 
mixture  of two  forms of the  protein-the  NH2 terminally  pro- 
cessed pro form and the mature GPI-linked form. The mutants that 
are not processed at the COOH terminus exhibit  a compact band 
of the pro form at '~65 kD. The minor product migrating fastest 
on the gel ('~60 kD) is nascent preproPLAP. (B) The wild-type and 
mutant forms of PLAP that are released  by PI-PLC from the cells 
into the medium are shown in this panel. They represent  the GPI- 
linked  forms of PLAP ('~67 kD). 
Figure 3. Expression of w +  2 
mutants  of  PLAP  in  COS 
cells.  Ceils  were labeled  with 
[35S]methionine following 
which cell lysates and PI-PLC 
treated  supernatants  were im- 
munoprecipitated  as described 
under  methods  and  the  leg- 
gend for Fig. 2. (A) Total PLAP 
from whole  cell  lysates.  (B) 
Wild-type and w +  2 mutant forms of PLAP that were released by 
PI-PLC from the cell  surface into the medium. 
alanine ~  glycine >  serine >> threonine and valine.  It was 
the wild-type,  serine and glycine mutants  which exhibited 
broadened peaks in Fig. 3 A, indicating that each represented 
a  mixture  of proPLAP (65  kD) and GPI-anchored PLAP. 
Those o~ +  2 mutants that showed little or no release by PI- 
PLC (Fig.  3 B) gave sharp bands at ca. 65 kD in Fig. 3 A, 
indicating  that  they  represented  largely  the  proforms  of 
PLAP  and  had  not  been  processed  to  the  GPI-anchored 
form. 
Expression of Enzymatically Active PLAP 
Processing of  the COOH terminus is a prerequisite for PLAP 
to be expressed on the cell surface (18, 19). Transfected cells, 
both w +  1 and w +  2 mutants, were homogenized and total 
PLAP enzyme activity was assayed. As shown in Table I A, 
all w +  1 mutants, except proline and tryptophan, exhibited 
Table L PLAP Enzyme Activity in COS Cells 
Transfected with Various Mutants 
(A) Total cellular  (B) Enzyme activity 
enzyme activity  released by PI-PLC 
Mutant  oJ  +  1  w  +  2  ~  +  1  w  +  2 
(milliunits/~ lO  ~ cells) 
Ala*  103  84  123  91 
Arg  38  -  48  - 
Asp  24  9  66  0 
Cys  18  0  38  5 
Glu  -  2  -  0 
Gly  -  63  -  78 
His  -  5  -  0 
Met  17  -  28  - 
Pro  1  4  0  0 
Ser  27  16  114  31 
Thr  22  10  39  11 
Trp  6  -  6  - 
Val  -  10  -  8 
For total enzyme activity each value represents the average of duplicate anal- 
yses obtained in one experiment. With respect to PIPLC activity released into 
the medium at least three different experiments were carried out with each mu- 
tant. Because of differences in transfection efficiency, values from only one of 
the experiments are shown. Although the absolute values obtained varied from 
transfection to transfection, the relative value for each mutant with respect to 
the wild type was fairly constant. Values for mock transfections averaged about 
1.5 milliunlt and were substracted as background. 
It should be noted that more measurable enzyme activity was released into 
the medium by PIPLC than was present in the cells before treatment with the 
lipase. This is so because in homogenates of cells the GPI-anchored PLAP is 
attached to  membrane  fragments and has a  lower specific activity than the 
PLAP that is solubilized by lipase treatment. In addition, because cell lysates 
are slightly turbid, measurement of enzyme activity is not as precise as it is 
in supernatants after PI-PLC release. 
* Indicates the wild type amino acid present at the ,~  +  1 or o~ +  2 positions. 
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significantly, treatment with PI-PLC did not release PLAP 
enzyme activity from cells transfected with the proline to + 
1 mutant (Table I B). Some enzyme was released from cells 
transfected  with  the  tryptophan  mutant;  considerable 
amounts of PLAP activity were released from all other mu- 
tants. These findings are in agreement with the data in Fig. 
2 B. Total PLAP enzyme activity in to +  2 transfected cells 
is also shown in Table I A. Only the glycine mutant exhibited 
activity comparable to the wild-type. Except for serine, all 
the others yielded 10% or less of the activity of wild-type 
PLAP. Again,  monitoring enzyme activity released by PI- 
PLC is most revealing. Only the glycine and serine to  +  2 
mutants yielded appreciable activity while most other mu- 
tants were either totally inactive or exhibited 10% or less of 
the wild-type activity. These findings are again in accord 
with the metabolic labeling experiments shown in Fig. 3 B. 
Immunocytochemical Localization of  Mutant 
Forms of  PLAP 
Mature GPI-anchored PLAP is present on the outer surface 
of the plasma membrane. To determine what forms of PLAP 
were expressed by COS cells after transfection with mutant 
cDNAs, the ceils were examined by immunofluorescent mi- 
croscopy with  and  without  permeabilization.  Only  those 
forms of PLAP that are on the cell surface should be visible 
before permeabilization, while permeabilized cells should 
also  permit visualization of intracellular  forms  of PLAP 
(prepro and proPLAP) (29).  Representative mutants were 
investigated. As shown in Fig. 4, PLAP from the methionine 
and threonine mutants at the to +  1 site (residue 485), as well 
as alanine were present predominantly on the cell surface 
similar to the wild-type. However, only after permeabiliza- 
tion was the to +  1 proline mutant seen within the cells indi- 
cating that it was expressed but not processed to the mem- 
brane anchored form. Of the to  +  2 mutants, only glycine 
exhibited surface fluorescence approaching that of the wild- 
type  (alanine)  (Fig.  5).  The valine mutant  yielded some 
fluorescence and the aspartic acid mutant essentially none. 
After permeabilization all to +  2 mutants yielded consider- 
able  fluorescence indicating,  once more,  that  processing 
rather than expression was the limiting factor in producing 
PLAP that  reached the  cell  surface.  These  immunocyto- 
chemical observations agree with and support the biochemi- 
cal finding presented above. 
Discussion 
A comparison between our earlier findings with miniPLAP 
mutants  in  cell-free  preparations  (11) and  our  present 
findings  in  COS  ceils transfected with mutant  cDNAs of 
PLAP show fairly good agreement in Table II. Both studies 
demonstrate a relative lack of specificity at the to  +  1 site 
and rather stringent requirements at the to +  2 site. It is of 
interest that in the cell-free studies with miniPLAP only gly- 
cine could substitute effectively at the to +  2 site for wild- 
type alanine. By contrast, in the current studies with PLAP 
mutants in intact cells, serine was '~30 to 50% as effective 
as alanine or glycine and the threonine and valine mutants 
demonstrated low but measurable activity. There could be 
many reasons why to +  2 substitution is more limited in the 
cell-free system than it is in intact cells. An obvious one is 
Figure 4. Detection of PLAP encoded by wild-type and selected 
co +  1 mutant cDNAs in transfected COS ceils. Transfected ceils 
were fixed  and nonspecific binding sites blocked with normal goat 
serum. Intact and permeabilized cells were treated with anti-PLAP 
antibodies and bound  antibody was visualized by staining with 
fluorescein-conjugated rabbit  anti-rabbit  immunoglobulin  anti- 
bodies. 
that  although  PLAP and  miniPLAP have the  same  NH2- 
and COOH-terminal sequences, they are different proteins. 
Mature PLAP contains 484 residues and is N-glycosylated 
whereas mature miniPLAP contains 179 residues and is not 
glycosylated (14).  Conceivably, secondary structure and the 
extent of  glycosylation  of  a protein during the transamidation 
reaction with the GPI moiety might be factors in selection 
of to  +  2 sites. Ideally one should use the same protein to 
compare cellular and  cell-free processing.  Unfortunately, 
native GPI-anchored proteins are frequently large and also 
N-glycosylated. Accordingly, they do not lend themselves 
readily to monitoring small changes in molecular mass that 
occur during  NH2-  and  COOH-terminal  processing  in  a 
cell-free system (19). Conversely, miniPLAP, which was de- 
signed specifically for cell-free studies is not processed as 
well in intact cells (14), perhaps because of its lack of  N-gly- 
cosylation sites.  Nevertheless, agreement between the two 
studies is fairly good as is agreement between experimen- 
tally determined values and those observed in characterized 
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Acid Substituents at the r  + 1, and o~ + 2 positions 
Mutant  ~  ~  +  1  o~ +  2 
Ala  0.4+  1.0  (1.0)+*  1.0 (1.0)+* 
Arg  ND  0.5  (0.7)  ND 
Ash  0.8 +  +  ND 
Asp  0.4+*  0.4  (0.6)+  0.1  (0) 
Cys  0.2+  0.3  (1.2)  0  (0) 
Gin  0  ND  ND 
Glu  0  (0.4)+  0  (0) 
Gly  0.4+  +  0.7  (0.6)+ 
His  ND  ND  0  (0) 
Leu  0.1  ND  ND 
Lys  0  ND  ND 
Met  0  0.3  (0.7)  ND 
Pro  0  0  (0)  0  (0) 
Ser  1.0+  0.6  (1.2)+  0.3  (0)+ 
Thr  0  0.3 (0.7)+  0.1  (0)+ 
Trp  0  0.1  (0)  ND (0) 
Tyr  0  ND  ND 
Val  0.1  ND  0.1  (0) 
Values for the oJ position have been calculated from an earlier report (18). Each 
value for ~0 +  1 and ~0  +  2 represents the average of all experiments  carried 
out on that mutant not only the ones shown in Table I. For each site, the mutant 
yielding highest activity was arbitrarily assigned a value of 1.0; all other values 
are relative to the most active mutant. The calculation of probabilities for w +  1 
and o~ +  2 substitution discussed in the text uses only the data obtained in the 
current experiments in cells transfected with PLAP eDNA and the various mu- 
tant cDNAs. Numbers in parenthesis under oJ +  1 and ~  +  2 are values previ- 
ously reported  for in vitro experiments  with miniPLAP  (11) and are shown 
here only to compare with the data obtained with PLAP in intact cells.  A  + 
indicates that this amino acid is present at the corresponding site of a character- 
ized GPI protein. 
* Denotes the wild type amino acid present at the respective position in PLAP. 
Figure 5.  Detection of PLAP encoded by wild-type and selected 
r  + 2 mutant cDNAs in transfected COS cells. Details as in legend 
to Fig. 4. 
GPI proteins (Table ID.  While not all possible mutants at 
the o~ +  1 and o0 +  2 sites were produced at least one repre- 
sentative  of each  class  of amino  acids  was  investigated. 
Tryptophan is  representative of the  aromatic amino acids 
phenylalanine and tyrosine; methionine and valine also rep- 
resent the long chain amino acids leucine and valine; argi- 
nine represents lysine as well; asparagine is representative 
of glutamine; and aspartic acid is representative of glutamic 
acid. 
Selection of the o~, 60 +  1, and r  +  2 sites for mutational 
studies was based on observations on the twenty or so pro- 
teins that have been fully characterized, i.e., have been both 
cloned and have had their ~0 sites determined  (8,  11). Al- 
though we have not carried out mutational  studies at sites 
preceding the ~o site (i.e., o~ -  1 or r  -  2) these are highly 
variable in all the fully characterized GPI-anchored proteins. 
Based on deletion mutations preceding the oJ site in DAF, 
Caras et al. (7) concluded that "residues immediately NH2- 
terminal to this region do not appear to play an essential role" 
as determinants in COOH-terminal processing. Earlier mu- 
tational  studies at the r  site revealed that only one of six 
small amino acids (Table II) could serve effectively (14,  18, 
19).  Direct  observations of the  r  +  1  sites  in  the  fully 
characterized GPI-anchored proteins (11) show some prefer- 
ence for small amino acids. However, this selectivity has not 
been borne out in site mutational studies in which arginine, 
methionine,  and  threonine  proved quite  effective. In fact, 
glutamic acid and asparagine are present at ~o +  1 sites in 
characterized proteins  (human Thy  1 and VSG MIT 221, 
respectively) (11). Interestingly, mutational studies at the r 
+  2  site indicate an even greater selectivity than has been 
observed at that site among the characterized GPI-ancbored 
proteins. Thus, r  and r  +  2 appear to serve as the amino 
acid determinants for cleavage and GPI attachment. 
One should consider the possibility that a mutation at any 
of the sites, r  ~0  +  1, or r  +  2 that leads to a GPI-linked 
protein, might shift the reading frame so as to convert an up- 
stream site (i.e., ~o -  3 or r  -  4) to a new GPI site. Obvi- 
ously, frameshifts of this kind would lead to cleavage at a site 
preceding the normal GPI attachment site, which in PLAP 
is Asl  ~u. Such frameshifts towards the amino terminus can 
be ruled out in these studies because the mutants were found 
to react with an antibody directed to the COOH-terminal se- 
quence  of  mature  PLAP,  CDLAPPAGTTD  ~.  We  have 
shown that when ASl  y~ is removed the epitope is lost (un- 
published results). Since 00 +  1 and o~ +  2 mutants reacted 
with this antibody, cleavage and GPI addition could not oc- 
cur at a  residue preceding the r  site (data not shown). 
The similarity between COOH-terminal signal transami- 
dase  and  NH2-terminal  signal  peptidase  with  respect  to 
amino  acid  substituents  at  their  cleavage  sites  was  first 
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Figure  6.  Binding of NH2- and COOH-terminal  signal peptides 
with their respective cleavage enzymes. (A) Representation of the 
lumenal portion of NH~-terminal signal peptidase with a  signal 
peptide bound at the  -1 and  -3 sites is adapted from the model 
proposed by yon Heijne (31). The arrowhead indicates the site of 
cleavage between the -1 site of the signal peptide and the +1 site. 
The latter represents the NH~ terminus of the mature protein. (B) 
Representation  of the  lumenal  portion  of the  putative  COOH- 
terminal transarnidase with a  signal peptide bound at the o~ and 
o~ +  2 sites.  The arrowhead indicates the site of cleavage between 
the  o~  +  1 site of the signal peptide and the o~ site.  The latter 
represents the COOH terminus of the mature protein, which con- 
comitant with cleavage, combines with the NH: group of the GPI 
moiety. The transamidase is shown in the lumen in a vertical posi- 
tion to emphasize similarities between the binding sites of the two 
cleavage enzymes. 
pointed out by Ferguson and Williams (10) and experimen- 
tally verified by us, initially using miniPLAP in a cell-free 
system (11) and currently with PLAP in intact cells. In both 
signal peptides only the first and third residues at the cleav- 
age site have a requirement for small amino acids. In the case 
of NH~-terminal signal peptidase  this  is referred to as the 
-1,  -3  rule  for predicting  the  site  of cleavage  of a  eDNA 
deduced  sequence  in a  protein containing  a  typical hydro- 
phobic NH~-terminal signal peptide (31). According to von 
Heijne (31, 32) the significance of the -1, -3 requirements are 
that these two amino acids represent sites of interaction with 
the  NH:-terminal  signal  peptidase.  The  mechanism  pro- 
posed  by  von  Heijne  for interaction  of the  NH~-terminal 
signal peptide with the peptidase is shown in Fig.  6 A  (31, 
32). The -1, -3 rule, which is generally accepted among mo- 
lecular biologists as a useful means of predicting the amino 
terminus of a mature protein based on its eDNA deduced se- 
quence,  has an acknowledged reliability of 75 to 80%  (31, 
32).  Our  studies  with  miniPLAP  in a  cell-free processing 
system suggested a  comparable mechanism whereby the ~0 
and o~ +  2 substituents represent key recognition sites for in- 
teraction with the putative COOH-terminal signal transami- 
dase (Fig. 6 B). The present studies confirm such a mecha- 
nism so that we may consider the 60 and o~ +  2 substituents 
as fairly reliable predictors of the COOH-terminal process- 
ing  site in a  nascent GPI-anchored protein. 
The  eDNA  deduced  COOH-terminal  regions  of  eight 
characterized  GPI-anchored  proteins  are  shown in  Fig.  7. 
Generally,  COOH-terminal  signal  peptides  contain  15-30 
residues.  The region between 60  +  1 and ,,oo~ +  8 is gener- 
ally, but not always, rich in charged amino acids and/or pro- 
line. A similar stretch of amino acids rich in charged amino 
acids  and  proline  precedes  the  cleavage  sites  of  NH2- 
t~ 
.... ssnl~l  &  &  I~V~&~L&~VVrrSIZSL~I&AGVGr~V 
(17,~) 
.... flYGyS~,T  e  ~  SS~FGt~LA|L&P~VLCLS~L  (11 
~1) 
g.  ----mGseGrLTTIS  a  Zl  v  TII  a  e~lt  L~r  I  L~G~LV  T  LVTI4~  LL  T 
o~ 
Figure 7. cDNA-deduced COOH-terminal regions of several GPI- 
anchored membrane proteins. The arrow indicates sites of cleavage. 
The highlighted amino acids represent o~, o~ +  1, and oJ +  2 sites, 
respectively, and  circled  amino acids are within putative hinge 
regions. The underlined sequences in each protein bracket residues 
with some degree of probability as representing the actual cleavage 
site based on hierarchial values in Table II. The numbers under each 
line represent the relative probability of each putative o~, oJ + 2 site. 
The experimentally determined 60, oJ +  2 sequence in each protein 
is underlined in bolder type. The proteins are as follows:  1, GAS 1 
(Saccharomyces  cerevisiae); 2, Thy-1 (human); 3, 5'-nueleotidase; 
4, alkaline phosphatase (human placenta); 5, renal dipeptidase; 6, 
promastigote surface protease GP63 (L. major);  7, VSG YNat 1.1 
( Trypanosoma congolense);  and 8, decay accelerating factor. Pro- 
tein 9 represents the deduced COOH-terminal amino acid sequence 
of a chimeric eDNA obtained by combining portions of three un- 
related cDNAs. The oJ site (boxed) is based on the site of cleavage 
proposed by the authors but not experimentally verified. The un- 
derlined sequences represent possible GPI attachment sites based 
on the o0, ~o +  2 rule. 
terminal signal peptides and is referred to as the hinge region 
(13). In the case of GPI-anchored proteins, a putative hinge 
region (circled amino acids, Fig. 7) is followed by a stretch 
of 8 to 20 highly hydrophobic amino acids. Occasionally, the 
hydrophobic  region  contains  or  terminates  in  a  charged 
amino acid or proline.  Determining the most probable site 
for GPI anchoring in a  cDNA deduced protein should take 
all the above factors into account: the size of the hydrophobic 
sequence,  the hinge region,  as well as the probabilities for 
the various amino acids to reside at the o~, ~0 +  1, and oJ + 
2 sites. It appears that, except for proline and tryptophan, al- 
most all substitutions at the ~0 +  1 site are effective. We can 
therefore limit considerations to the ~0 and 00  +  2  sites and 
rule out putative o~ sites that are followed by a proline or tryp- 
tophan.  Using the hierarehial  values  determined  for these 
two sites (Table II), the probability of a specific amino acid 
being the oJ site for GPI anchoring in a given nascent protein 
would then be arrived at by multiplying the individual proba- 
bilities of o0 and 00  +  2 constituents.  Thus, if serine at an ~o 
site has a probability of 1 and alanine at o~  +  2  also has a 
probability of 1 the resultant probability would be 1  ￿  1 = 
1.00 (most probable). Cysteine at an ~o site has a probability 
of 0.2 and with an alanine at a putative o~ +  2 site the overall 
probability would be 0.2  (less probable).  However,  if cys- 
teine were at the o~ site and the o~ +  2  site were serine (0.3) 
then  the overall probability  for each  motif would  be 0.06 
(even less probable). Thus, in Fig. 7 an o~, ~o +  2 rule would 
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first six proteins. Based only on the o~, o~ +  2 rule, protein 
7 has a site of higher probability (S-H-G) immediately fol- 
lowing the experimentally determined site (S-G-S). It should 
be noted, however, that the S-H-G site is within a  typical 
hinge area (circled amino acids) and is also very close to the 
COOH terminus of the signal peptide thereby making the 
S-G-S site the more likely. Protein eight contains three possi- 
ble sites yet it is one with a lower probability that is actually 
the site of cleavage and GPI attachment (21). Thus, proteins 
7  and  8  indicate  that  other  factors,  including  secondary 
structure, or location within a hinge region must also play 
significant roles as determinants. Nevertheless, application 
of the ~, o~  +  2 rule, based on data in Table II, to the 20 
fully characterized GPI-anchored proteins (reference 11, Ta- 
ble I) indicate that it is a fairly good predictor of the site of 
cleavage and GPI addition. In three proteins (reference 11, 
Table I; proteins 9,  17, and 19), the observed oJ site was the 
only one with any degree of probability. In twelve other in- 
stances (reference 11, Table I; proteins 1, 3, 5-8, 10, 11, 14- 
16, and 18) more than one site was possible but the verified 
site had by far the highest probability. In two of the proteins 
(reference 11, Table I; proteins 12 and 13), the verified o: site 
was one of two with about equal probabilities. However, in 
three proteins (reference 11, Table I; proteins 2, 4, and 20) 
the actual cleavage site had a lower probability than one at 
a nearby site(s). In two of these cases the more probable site 
was towards the NH2 terminus and in one case, toward the 
COOH terminus. It should be noted, however, that in all the 
characterized proteins the verified oJ site was one with some 
degree of probability. Thus, an o~, o~ +  2 rule by itself would 
have predicted the correct cleavage site in 75 % of the cases 
and would have limited selection to two possible sites in an- 
other 10%. If one rules out probable sites within a hinge re- 
gion, predictability is even greater. 
This brings up the recent report by Moran and Caras (20) 
on an interesting series of chimeric proteins in which ele- 
ments from non-anchored proteins are fused to generate a 
functional signal(s) for GPI membrane anchor attachment. 
Protein 9 in Fig. 7 shows one of their constructs. What is in- 
teresting and significant is that, core hydrophobic portions 
from HN2-terminal signal peptides from secreted proteins 
such as prolactin and human growth hormone could be sub- 
stituted successfully for the COOH-terminal signal peptide 
of DAE These findings further emphasize the similarities be- 
tween  NH2-  and  COOH-terminal  processing.  However, 
Moran and Caras (20) went on to conclude that unlike the 
NH2-terminal  processing  signal  of  two  alternate  small 
amino acids (-1, -3),  COOH-terminal processing and GPI 
addition requires only two consecutive small amino acids 
(i.e., o~, w +  1). Such a conclusion is not borne out by pub- 
lished reports of other GPI anchored proteins (Fig.  7 and 
references 8, 10, 30) or by our experimental findings. It must 
be pointed out, however, that the serine claimed to be the site 
of cleavage in most of the chimeric proteins produced by 
Moran  and  Caras  (20),  was  only  inferred,  and  not  ex- 
perimentally verified. Nevertheless, the sequence of S-G-I 
in one of the constructs does have some probability (as noted 
in Fig. 7). If one assumes that isoleucine at o~ +  2 (which 
we did not investigate) is as probable as valine or methionine 
(0.1 then the overall probability would be 0.1. It should be 
noted however, that, seven residues towards the NH2 termi- 
nus there is a far more likely 60, oJ +  2 site, S-C-G, with a 
probability of 0.7. All the other constructs contain several 
probable sites in addition to the ones listed above. We fail 
to see how a study with chimeric proteins in which the o~ sites 
were not experimentally determined and where no site muta- 
tions were made can claim that only two consecutive small 
amino acids can serve as a  signal for GPI anchoring. 
Studies with purified GPI transamidase and synthetic pep- 
tide  analogs  of COOH-terminal  signal  peptides  will  be 
necessary to more firmly establish the o~, o~ +  2 requirement 
for GPI anchoring. Until then application of an ~, w +  2 rule 
can be of  value in helping to determine the site of GPI attach- 
ment in a cDNA deduced sequence of a protein. By narrow- 
ing the number of possible sites to one or two it limits the 
experiments required to establish the GPI site experimen- 
tally (17, 23,  24). Information from the o:, o~ +  2 rule can 
also be used to develop site-directed antibodies to help moni- 
tor studies on the biosynthesis ofa GPI-anchored protein (2). 
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